Skip to main content
. 2021 Aug 29;13:20363613211034710. doi: 10.1177/20363613211034710

Figure 2.

Figure 2.

(a) PET scan of pre-denosumab showed metabolically active lesion in sacrum and (b) post-denosumab showed no metabolic activity.